Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: a European policy review

Objectives To examine the accessibility and quality of drug company payment data in Europe.Design Comparative policy review of payment data in countries with different regulatory approaches to disclosure.Setting 37 European countries.Participants European Federation of Pharmaceutical Industries and...

Full description

Saved in:
Bibliographic Details
Main Authors: Piotr Ozieranski, Shai Mulinari, Luc Martinon, Pierre-Alain Jachiet
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/12/e053138.full
Tags: Add Tag
No Tags, Be the first to tag this record!